Moody Aldrich Partners LLC Bio Xcel Therapeutics, Inc. Transaction History

Moody Aldrich Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$29.06 - $38.83 $588,377 - $786,191	-20,247 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$39.04 - $64.6 $12,961 - $21,447	332 Added 1.67%	20,247 $874,000
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $1,825 - $2,432	43 Added 0.22%	19,915 $920,000
Q3 2020 Nov 12, 2020	BUY	$37.44 - $64.63 $18,532 - $31,991	495 Added 2.55%	19,872 $862,000
Q2 2020 Jul 30, 2020	SELL	$17.62 - $58.71 $1.06 Million - $3.54 Million	-60,265 Reduced 75.67%	19,377 $1.03 Million
Q1 2020 May 07, 2020	BUY	$12.26 - $41.14 $976,410 - $3.28 Million	79,642 New	79,642 $1.78 Million

8.63M

34.5K

59.4K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $63.9M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.